Antidepressants and the risk of breast cancer

Canadian Journal of Psychiatry

Volumn 47, Issue 10, 2002, Pages 966-970

  Kurdyak, Paul A ^a,c   Gnam, William H ^a   Streiner, David L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Antidepressant; Breast cancer; Case control study design; Depression

Indexed keywords

ANTIDEPRESSANT AGENT; PAROXETINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; DEPRESSION; DRUG SAFETY; HUMAN; RISK ASSESSMENT;

EID: 0036992204     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370204701009     Document Type: Article

References (12)

1. Sharpe CR, Collet J-P, Belzile E, Hanley JA, Boivin J-F. The effects of tricyclic antidepressants on breast cancer risk. Br J Cancer 2002;86:92-7.
2. Picard A. Research finds some depression drugs raise cancer risk. The Globe and Mail 2002;A1.
3. Parkin DM, Pisani P, Ferlay J. Esitmates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
4. Brewster A, Helzlsouer K. Breast cancer epidemiology, prevention, and early detection. Curr Opin Oncol 2001;13:420-5.
5. Madigan MP, Zeigler RG, Benichou J, and others. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995;87:1681-5.
6. Cotterchio M, Kreiger N, Darlington G, Steingart A. Antidepressant medication use and breast cancer risk. Am J Epidemiol 2000;151:951-7.
7. Van Schaik N, Graf U. Genotoxicity evaluation of five antidepressants in the wing somatic mutation and recombination test in Drosophila melanogaster. Mutat Res 1991;260:99-104.
8. Van Schaik N, Graf U. Structure-activity relationships of tricyclic antidepressants and related compounds in the wing somatic mutation and recombination test of Drosophila melanogaster. Mutat Res 1993;286:163.
9. Fisher LD, Van Belle G. Multiple Comparisons. In: Fisher LD, Van Belle G. Biostatistics: a methodology for the health sciences. New York: John Wiley and Sons; 1993. p 596-629.
10. Armstrong B, Stevens N, Doll R. Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Lancet 1974;2:672-5.
11. Reserpine and breast cancer. Lancet 1974;2:669-71.
12. Heinonen OP, Shapiro S, Tuominen L, Turunen MI. Reserpine use in relation to breast cancer. Lancet 1974;2:675-7.